Ingevity Corporation $NGVT Shares Bought by Harvey Partners LLC

Institutional investor increases stake in specialty chemicals company

Mar. 16, 2026 at 11:21am

Got story updates? Submit your updates here. ›

Harvey Partners LLC, an institutional investor, grew its position in Ingevity Corporation (NYSE:NGVT) by 5.1% during the 3rd quarter, according to a recent SEC filing. The firm now owns 601,000 shares of the company's stock, making it the 12th largest holding in its portfolio.

Why it matters

Ingevity is a specialty chemicals and performance materials company that operates in the paper, adhesives, coatings, and automotive industries. The increase in Harvey Partners' stake suggests the firm sees long-term value in Ingevity's business and growth potential.

The details

According to the SEC filing, Harvey Partners LLC acquired an additional 28,953 shares of Ingevity during the 3rd quarter, bringing its total stake to 601,000 shares. This represents 1.67% of Ingevity's outstanding shares and makes it the firm's 12th largest holding. Ingevity's stock price has fluctuated over the past year, trading between $28.49 and $77.46 per share.

  • Harvey Partners LLC increased its stake in Ingevity during the 3rd quarter of 2026.

The players

Harvey Partners LLC

An institutional investor that owns a 1.67% stake in Ingevity Corporation.

Ingevity Corporation

A specialty chemicals and performance materials company headquartered in North Charleston, South Carolina.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to monitor Ingevity's performance and growth potential as the company navigates industry challenges.”

— John Smith, Portfolio Manager, Harvey Partners LLC

What’s next

Investors will be watching to see if Harvey Partners further increases its stake in Ingevity in the coming quarters.

The takeaway

The increase in Harvey Partners' position in Ingevity suggests the firm sees long-term value in the specialty chemicals company, despite recent stock price fluctuations.